Venture Certified
| 기술평가보증기업(기금) | 2009-11-18 ~ 2011-11-17 | 20090110256 | 2009-11-18 |
| 기술평가보증기업(기금) | 2012-03-28 ~ 2014-03-27 | 20120102632 | 2009-11-18 |
| 기술평가보증기업(기금) | 2014-03-28 ~ 2016-03-27 | 20140106682 | 2009-11-18 |
| 기술평가보증기업(기금) | 2016-03-28 ~ 2018-03-27 | 20160106120 | 2009-11-18 |
| 기술평가보증기업(기금) | 2018-03-28 ~ 2020-03-27 | 20180104789 | 2009-11-18 |
| 기술평가보증기업(기금) | 2020-03-28 ~ 2022-03-27 | 20200103688 | 2009-11-18 |
| 혁신성장유형 | 2022-03-28 ~ 2025-03-27 | 20220421030066 | 2009-11-18 |
| 혁신성장유형 | 2025-03-28 ~ 2028-03-27 | 20250508030039 | 2009-11-18 |
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.0B | 0.0B | 0.0B |
| Operating Profit | -12B | -12B | -13B |
| Net Profit | -13B | -13B | -13B |
| Total Assets | 2.9B | 5.1B | 12B |
| Total Liabilities | 22B | 11B | 9.9B |
| Total Equity | -19B | -5.9B | 1.6B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -12B
3 Consecutive Years of Net Loss
- 0.0%
▲ 0.8%
▼ 155.0%
▲ 123.9%
| Name | Position | Role |
|---|---|---|
| 정도선 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "충청북도 청주시",
"ceo_name": "정도선",
"certificate": [
{
"cert_number": "20090110256",
"changes": "",
"disclosure_date": "2009-11-18",
"first_cert_date": "2009-11-18",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2009-11-18 ~ 2011-11-17"
},
{
"cert_number": "20120102632",
"changes": "",
"disclosure_date": "2012-03-28",
"first_cert_date": "2009-11-18",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-03-28 ~ 2014-03-27"
},
{
"cert_number": "20140106682",
"changes": "",
"disclosure_date": "2014-06-03",
"first_cert_date": "2009-11-18",
"no": "3",
"type": "기술평가보증기업(기금)",
"valid_period": "2014-03-28 ~ 2016-03-27"
},
{
"cert_number": "20160106120",
"changes": "",
"disclosure_date": "2016-05-24",
"first_cert_date": "2009-11-18",
"no": "4",
"type": "기술평가보증기업(기금)",
"valid_period": "2016-03-28 ~ 2018-03-27"
},
{
"cert_number": "20180104789",
"changes": "",
"disclosure_date": "2018-04-25",
"first_cert_date": "2009-11-18",
"no": "5",
"type": "기술평가보증기업(기금)",
"valid_period": "2018-03-28 ~ 2020-03-27"
},
{
"cert_number": "20200103688",
"changes": "",
"disclosure_date": "2020-03-27",
"first_cert_date": "2009-11-18",
"no": "6",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-03-28 ~ 2022-03-27"
},
{
"cert_number": "20220421030066",
"changes": "",
"disclosure_date": "2022-04-21",
"first_cert_date": "2009-11-18",
"no": "7",
"type": "혁신성장유형",
"valid_period": "2022-03-28 ~ 2025-03-27"
},
{
"cert_number": "20250508030039",
"changes": "",
"disclosure_date": "2025-05-08",
"first_cert_date": "2009-11-18",
"no": "8",
"type": "혁신성장유형",
"valid_period": "2025-03-28 ~ 2028-03-27"
}
],
"company_name": "(주)티이바이오스",
"corp_no": "160111-*******",
"financials": {
"2022": {
"capital_stock": 1317847000,
"cost_of_sales": 0,
"current_assets": 870045000,
"current_liabilities": 763724000,
"gross_profit": 0,
"net_income": -1286476000,
"net_income_bs": -1286476000,
"non_current_assets": 284561000,
"non_current_liabilities": 227738000,
"non_operating_expenses": 23309000,
"non_operating_income": 389000,
"operating_profit": -1263556000,
"revenue": 0,
"sga_expenses": 1263556000,
"total_assets": 1154606000,
"total_equity": 163144000,
"total_liabilities": 991462000
},
"2023": {
"capital_stock": 1337307000,
"cost_of_sales": 0,
"current_assets": 251345000,
"current_liabilities": 832383000,
"gross_profit": 0,
"net_income": -1262782000,
"net_income_bs": -1262782000,
"non_current_assets": 261701000,
"non_current_liabilities": 268921000,
"non_operating_expenses": 67055000,
"non_operating_income": 45717000,
"operating_profit": -1241444000,
"revenue": 0,
"sga_expenses": 1241444000,
"total_assets": 513046000,
"total_equity": -588258000,
"total_liabilities": 1101304000
},
"2024": {
"capital_stock": 1337307000,
"cost_of_sales": 0,
"current_assets": 110696000,
"current_liabilities": 1632500000,
"gross_profit": 0,
"net_income": -1277839000,
"net_income_bs": -1277839000,
"non_current_assets": 182555000,
"non_current_liabilities": 526848000,
"non_operating_expenses": 41170000,
"non_operating_income": 5460000,
"operating_profit": -1242129000,
"revenue": 0,
"sga_expenses": 1242129000,
"total_assets": 293251000,
"total_equity": -1866097000,
"total_liabilities": 2159348000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [],
"main_products": "인공각막개발",
"phone": "043-218-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 6/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Not Collected | Not Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |